Literature DB >> 12745168

Do people with type 2 diabetes and their carers lose income? (T2ARDIS-4).

Jeremy Holmes1, Elena Gear, Julia Bottomley, Stephen Gillam, Moira Murphy, Rhys Williams.   

Abstract

T(2)ARDIS is a study of the full costs of care for a sample of people with type 2 diabetes in the UK. This paper reports on individual earnings lost by patients (n=653) and carers (n=253) aged <65 years, based on 1998 values. Mean annual lost earnings are calculated on three different bases. Across the total survey population aged <65 years, mean lost earnings are estimated at pound 869 (S.D. pound 4109) per patient and pound 1300 (S.D. pound 4093) per carer. However, for the sub-set of respondents who actually lose earnings, the mean levels are pound 13841 (S.D. pound 9551) and pound 10960 (S.D. pound 6002), respectively. Patients and carers who lose earnings incur higher personal care-related expenditure than those who do not lose earnings (although for the patients this is not statistically significant). Patients who lose earnings also report poorer health-related quality of life and carers who lose earnings report higher levels of strain. Only one third of carers report receiving state benefits, and for both carers and patients the shortfall between reported benefits received and lost earnings is substantial. A strong association was found between patients' loss of earnings and the presence of diabetic complications (P<0.001), especially micro-vascular complications. Policy priorities should, therefore, include facilitating comprehensive access to state benefits (especially for carers) and a clear focus on reducing the incidence of diabetic complications.

Entities:  

Mesh:

Year:  2003        PMID: 12745168     DOI: 10.1016/s0168-8510(02)00177-x

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  6 in total

1.  Diabetes mellitus patients' family caregivers' subjective quality of life.

Authors:  Abdel W Awadalla; Jude U Ohaeri; Shafika A Al-Awadi; Adel M Tawfiq
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

2.  Type-2 Diabetes Mellitus (T2DM): Spatial-temporal Patterns of Incidence, Mortality and Attributable Risk Factors from 1990 to 2019 among 21 World Regions.

Authors:  Mehak Nanda; Rajesh Sharma; Sumaira Mubarik; Aashima Aashima; Kai Zhang
Journal:  Endocrine       Date:  2022-07-16       Impact factor: 3.925

3.  UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).

Authors:  Anthony H Barnett; Helen L Millar; Jean-Yves Loze; Gilbert J L'Italien; Marc van Baardewijk; Martin Knapp
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-03-09       Impact factor: 5.270

Review 4.  Individual patient education for people with type 2 diabetes mellitus.

Authors:  Sally-Anne S Duke; Stephen Colagiuri; Ruth Colagiuri
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

Review 5.  The Economic Costs of Type 2 Diabetes: A Global Systematic Review.

Authors:  Till Seuring; Olga Archangelidi; Marc Suhrcke
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981

6.  Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics.

Authors:  J M Khalid; M Raluy-Callado; B H Curtis; K S Boye; A Maguire; M Reaney
Journal:  Int J Clin Pract       Date:  2013-09-23       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.